ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,721, issued on Sept. 15, was assigned to The General Hospital Corp. (Boston) and President and Fellows of Harvard College (Cambridge, Mass.).
"Engineered adeno-associated (AAV) vectors for transgene expression" was invented by Casey A. Maguire (Arlington, Mass.), Eloise Marie Hudry (Roxbury Crossing, Mass.) and Killian S. Hanlon (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "Engineered AAV vectors for transgene expression, e.g., in the CNS, PNS, inner ear, heart, or retina, and methods of use thereof. Also provided are methods for discovering new engineered AAV vectors that mediate transgene expression in desired cell types."
The patent wa...